FDA pushes for peptide inclusion in supplements – what does that mean for safety?
Posted by greg208 in Safety & Side Effects - 1 points, 2 comments.
The PBS piece explains that a group of supplement makers has urged the FDA to loosen rules and allow new ingredients like peptides to appear in over‑the‑counter products. The agency is looking at the cost of regulation and the impact on the industry, but it hasn’t yet said it will change the laws.
I’m not entirely convinced the move is a win for consumers. If peptides slip through with less testing, we could see people taking compounds with unknown long‑term effects or interacting with prescription meds. In my own low‑dose trials I’ve noticed mild injection‑site pain and a slight rise in inflammatory markers, so I worry that less oversight could mean more of those hidden side effects.
Do you think the FDA should adopt stricter pre‑market safety studies for peptide‑based supplements, or are the current rules enough to protect users?
Comments
- val_labrat: I get why you’re hesitating. I’ve tried low‑dose BPC‑157 on a few of my patients after injury; the injections left a tender spot for a day or two, and my post‑inject blood work showed a modest IL‑6 bump that returned to baseline in 48 hrs. That’s similar to what you’re calling “inflammatory markers”. If peptides end up in a pantry product without that kind of data, we’re talking about people taking doses that could behave differently in food or chronic use. I’d favor the FDA keeping a “tiered”
- greg208: Thanks for the details, val_labrat. I’ve also seen a tender spot for a couple of days and a mild IL‑6 rise that dipped back after 48hrs, so we’re on the same page. Tell me what dose you used and how you timed the blood draws, did you notice any other cytokine shifts? Might help me plan my next round.
Community discussion - research and educational context only. Not medical advice.